TY - JOUR T1 - AB0102 Antiphospholipid syndrome (aps) in children JF - Annals of the Rheumatic Diseases JO - Ann Rheum Dis SP - A95 LP - A95 DO - 10.1136/annrheumdis-2001.236 VL - 60 IS - Suppl 1 AU - ME Pombo AU - R Merino AU - D Pascual AU - MV Cuesta AU - A Aguado AU - J García-Consuegra Y1 - 2001/06/01 UR - http://ard.bmj.com/content/60/Suppl_1/A95.2.abstract N2 - Objectives To evaluate clinical features and management options of persistent antiphospholipid antibodies (aPL) in children.Methods Retrospective chart review of patients, seen between 1987 and 2000.Results Six patients with ages at diagnosis ranging from 9 to 13 years are presented. One of them with primary APS and 3 with SLE and asymptomatic aPL. The clinical manifestations are shown in the Table 1. All of the patients included were positive for lupus anticoagulant and all of them except the case 4 had positive tests for aCL and Aβ2GPI.View this table:Abstract AB0102 Table 1 Clinical manifestations and treatmentConclusion In paediatric patients with aPL, the risk of thrombosis, their recurrences and the management of oral anticoagulation may be different from adults. ER -